The Platform Group AG is in advanced negotiations to acquire three pharmaceutical platform companies in Germany, Austria, and the Czech Republic. The acquisitions, valued in the double-digit million-euro range, are expected to add annual revenue in the low three-digit million-euro range. The move aims to significantly expand the company’s presence in the market. To finance the transactions, The Platform Group is considering increasing its existing corporate bond. The company closed trading at EUR 8.42 on the XETRA on Thursday. Letters of intent were signed in August, with purchase agreements targeted for September.

Read more at Nasdaq: The Platform Group In Talks To Buy Three Pharma Platforms, Considers Bond Tap